PortfoliosLab logoPortfoliosLab logo
VALE vs. DGX
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

VALE vs. DGX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Vale S.A. (VALE) and Quest Diagnostics Incorporated (DGX). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, VALE achieves a 20.57% return, which is significantly higher than DGX's 18.06% return. Over the past 10 years, VALE has outperformed DGX with an annualized return of 22.05%, while DGX has yielded a comparatively lower 12.33% annualized return.


VALE

1D
2.28%
1M
-6.71%
YTD
20.57%
6M
23.80%
1Y
73.31%
3Y*
12.85%
5Y*
2.38%
10Y*
22.05%

DGX

1D
-0.38%
1M
6.40%
YTD
18.06%
6M
12.22%
1Y
15.46%
3Y*
16.40%
5Y*
11.96%
10Y*
12.33%
*Multi-year figures are annualized to reflect compound growth (CAGR)

VALE vs. DGX - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
VALE
Vale S.A.
20.57%60.70%-38.83%1.57%32.54%-1.45%32.40%2.72%12.25%68.03%
DGX
Quest Diagnostics Incorporated
18.06%17.20%11.77%-10.05%-7.80%47.86%14.11%31.13%-13.84%9.16%

Correlation

The correlation between VALE and DGX is 0.09, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.09

Correlation (3Y)
Calculated over the trailing 3-year period

0.15

Correlation (5Y)
Calculated over the trailing 5-year period

0.14

Correlation (10Y)
Calculated over the trailing 10-year period

0.17

Correlation (All Time)
Calculated using the full available price history since Mar 21, 2002

0.22

The correlation between VALE and DGX shifts across timeframes, from 0.09 (1 year) to 0.22 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

VALE:

$67.15B

DGX:

$22.74B

EPS

VALE:

$0.65

DGX:

$9.10

PE Ratio

VALE:

24.04

DGX:

22.31

PS Ratio

VALE:

1.70

DGX:

2.03

PB Ratio

VALE:

1.83

DGX:

3.09

Total Revenue (TTM)

VALE:

$39.53B

DGX:

$11.28B

Gross Profit (TTM)

VALE:

$13.65B

DGX:

$3.75B

EBITDA (TTM)

VALE:

$14.33B

DGX:

$1.98B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

VALE vs. DGX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

VALE
VALE Risk / Return Rank: 8989
Overall Rank
VALE Sharpe Ratio Rank: 9292
Sharpe Ratio Rank
VALE Sortino Ratio Rank: 8888
Sortino Ratio Rank
VALE Omega Ratio Rank: 8888
Omega Ratio Rank
VALE Calmar Ratio Rank: 8888
Calmar Ratio Rank
VALE Martin Ratio Rank: 9191
Martin Ratio Rank

DGX
DGX Risk / Return Rank: 6464
Overall Rank
DGX Sharpe Ratio Rank: 6565
Sharpe Ratio Rank
DGX Sortino Ratio Rank: 6161
Sortino Ratio Rank
DGX Omega Ratio Rank: 5858
Omega Ratio Rank
DGX Calmar Ratio Rank: 6868
Calmar Ratio Rank
DGX Martin Ratio Rank: 6767
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

VALE vs. DGX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Vale S.A. (VALE) and Quest Diagnostics Incorporated (DGX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


VALEDGXDifference
Sharpe ratioReturn per unit of total volatility

+1.62

Sortino ratioReturn per unit of downside risk

+1.66

Omega ratioGain probability vs. loss probability

1.37

1.14

+0.23

Calmar ratioReturn relative to maximum drawdown

3.71

1.34

+2.37

Martin ratioReturn relative to average drawdown

12.21

2.79

+9.42

VALE vs. DGX - Sharpe Ratio Comparison

The current VALE Sharpe Ratio is 2.30, which is higher than the DGX Sharpe Ratio of 0.68. The chart below compares the historical Sharpe Ratios of VALE and DGX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

VALE vs. DGX - Drawdown Comparison

The maximum VALE drawdown since its inception was -92.78%, which is greater than DGX's maximum drawdown of -49.46%. Use the drawdown chart below to compare losses from any high point for VALE and DGX.


Loading charts...

Drawdown Indicators


VALEDGXDifference

Max Drawdown

Largest peak-to-trough decline

-92.78%

-49.46%

-43.32%

Max Drawdown (1Y)

Largest decline over 1 year

-19.85%

-11.55%

-8.30%

Max Drawdown (3Y)

Largest decline over 3 years

-41.94%

-16.57%

-25.37%

Max Drawdown (5Y)

Largest decline over 5 years

-49.79%

-28.62%

-21.17%

Max Drawdown (10Y)

Largest decline over 10 years

-57.60%

-36.60%

-21.00%

Current Drawdown

Current decline from peak

-11.84%

-3.76%

-8.08%

Average Drawdown

Average peak-to-trough decline

-36.69%

-11.89%

-24.80%

Ulcer Index

Depth and duration of drawdowns from previous peaks

6.02%

5.56%

+0.46%

Volatility

VALE vs. DGX - Volatility Comparison

Vale S.A. (VALE) has a higher volatility of 9.16% compared to Quest Diagnostics Incorporated (DGX) at 6.09%. This indicates that VALE's price experiences larger fluctuations and is considered to be riskier than DGX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


VALEDGXDifference

Volatility (1M)

Calculated over the trailing 1-month period

9.16%

6.09%

+3.07%

Volatility (6M)

Calculated over the trailing 6-month period

26.35%

16.94%

+9.41%

Volatility (1Y)

Calculated over the trailing 1-year period

32.06%

23.01%

+9.05%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

35.47%

21.81%

+13.66%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

40.84%

23.79%

+17.05%

Dividends

VALE vs. DGX - Dividend Comparison

VALE's dividend yield for the trailing twelve months is around 3.66%, more than DGX's 1.61% yield.


PositionTTM20252024202320222021202020192018201720162015
DGX
Quest Diagnostics Incorporated
1.61%1.82%1.96%2.02%1.66%1.40%1.85%1.99%2.34%1.83%1.72%2.07%
VALE
Vale S.A.
3.66%7.29%11.41%7.75%8.63%19.70%2.72%2.63%4.16%3.77%1.06%7.48%

Financials

VALE vs. DGX - Financials Comparison

This section allows you to compare key financial metrics between Vale S.A. and Quest Diagnostics Incorporated. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


5.00B10.00B15.00B20222023202420252026
9.26B
2.90B
(VALE) Total Revenue
(DGX) Total Revenue
Values in USD except per share items

VALE vs. DGX - Profitability Comparison

The chart below illustrates the profitability comparison between Vale S.A. and Quest Diagnostics Incorporated over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

30.0%40.0%50.0%60.0%70.0%20222023202420252026
33.0%
32.5%
Portfolio components
VALE - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Vale S.A. reported a gross profit of 3.06B and revenue of 9.26B. Therefore, the gross margin over that period was 33.0%.

DGX - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Quest Diagnostics Incorporated reported a gross profit of 942.00M and revenue of 2.90B. Therefore, the gross margin over that period was 32.5%.

VALE - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Vale S.A. reported an operating income of 2.67B and revenue of 9.26B, resulting in an operating margin of 28.8%.

DGX - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Quest Diagnostics Incorporated reported an operating income of 399.00M and revenue of 2.90B, resulting in an operating margin of 13.8%.

VALE - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Vale S.A. reported a net income of 1.89B and revenue of 9.26B, resulting in a net margin of 20.5%.

DGX - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Quest Diagnostics Incorporated reported a net income of 252.00M and revenue of 2.90B, resulting in a net margin of 8.7%.


Frequently Asked Questions


VALE and DGX have a correlation of 0.09, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

VALE has higher volatility (9.16%) compared to DGX (6.09%). In terms of maximum drawdown, VALE dropped -92.78% vs DGX's -49.46%.

VALE currently has the higher Sharpe Ratio (2.30 vs 0.68), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for VALE and DGX

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer